Search Results for “” – Page 17 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Clinical outcomes Change patient management Observational

236 Publications found

Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study.

b

Journal of Crohn's & colitis

August 29, 2018

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational Operational efficiencies
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

b

The New England journal of medicine

August 16, 2018

p Diabetes

c Change patient management Clinical outcomes Observational Operational efficiencies
EGFR T790M detection and osimertinib treatment response evaluation by liquid biopsy in lung adenocarcinoma patients with acquired resistance to first generation EGFR tyrosine kinase inhibitors.

b

Diagnostic pathology

August 13, 2018

p Cancer

c Change patient management Clinical outcomes Observational
Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting.

b

JAMA

August 7, 2018

p Cancer

c Change patient management Clinical outcomes Observational
Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of Infliximab.

b

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

August 1, 2018

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational
Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel Disease.

b

Journal of Crohn's & colitis

June 28, 2018

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational
Therapeutic Drug Monitoring Guides the Management of Crohn’s Patients with Secondary Loss of Response to Adalimumab.

b

Inflammatory bowel diseases

June 8, 2018

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational
Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.

b

Circulation. Cardiovascular interventions

June 1, 2018

p ACT Guided Heparinization

c Change patient management Clinical outcomes Highlighted Observational Safety
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans.

b

Oncotarget

April 3, 2018

p Cancer

c Change patient management Clinical outcomes Observational
The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas.

b

Oncotarget

February 16, 2018

p Cancer

c Change patient management Clinical outcomes Observational